Albany Molecular Research Inc (AMRI) - Financial and Strategic SWOT Analysis Review

Date: April 5, 2017
Pages: 58
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A8DAE2168FBEN
Leaflet:

Download PDF Leaflet

Albany Molecular Research Inc (AMRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Albany Molecular Research Inc (AMRI) is a contract research and manufacturing organization. Its service portfolio include drug discovery, such as discovery biology, medicinal chemistry, and in-vitro ADME; development, such as pre-formulation, formulation and validation; and manufacturing, such as cGMP API manufacturing; process scale up development of fine chemicals and aseptic filling services for preclinical, clinical and commercial projects; and project management services. The company serves pharmaceutical, agrochemical and other sectors including detergent and cosmetics industries. AMRI offers drug discovery and development services across various therapeutic categories including infectious diseases, neurodegenerative disorders, metabolic disorders, cardiovascular and oncology. It has presence in the US, Europe and Asia. AMRI is headquartered in Albany, New York, the US.

Albany Molecular Research Inc Key Recent Developments

Feb 21,2017: AMRI Announces Fourth Quarter and Full Year 2016 Results and Provides 2017 Outlook
Feb 07,2017: AMRI Announces Strategic Alliance to Advance Mass Spectrometry Capabilities for Drug Discovery
Nov 29,2016: AMRI Announces API Supply Agreement with Shire
Nov 08,2016: AMRI ANNOUNCES THIRD QUARTER 2016 RESULTS
Oct 03,2016: AMRI to Unveil Powerful Portfolio of APIs and Capabilities at CPhI in Barcelona

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Albany Molecular Research Inc - Key Facts
Albany Molecular Research Inc - Key Employees
Albany Molecular Research Inc - Key Employee Biographies
Albany Molecular Research Inc - Major Products and Services
Albany Molecular Research Inc - Pharmaceutical Pipeline Products Data
Albany Molecular Research Inc, Pipeline Products by Therapy Area
Albany Molecular Research Inc, Pipeline Products by Development Phase
Albany Molecular Research Inc - History
Albany Molecular Research Inc - Company Statement
Albany Molecular Research Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Albany Molecular Research Inc - Business Description
Albany Molecular Research Inc - Corporate Strategy
Albany Molecular Research Inc - SWOT Analysis
SWOT Analysis - Overview
Albany Molecular Research Inc - Strengths
Albany Molecular Research Inc - Weaknesses
Albany Molecular Research Inc - Opportunities
Albany Molecular Research Inc - Threats
Albany Molecular Research Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Albany Molecular Research Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Albany Molecular Research Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Albany Molecular Research Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 21, 2017: AMRI Announces Fourth Quarter and Full Year 2016 Results and Provides 2017 Outlook
Feb 07, 2017: AMRI Announces Strategic Alliance to Advance Mass Spectrometry Capabilities for Drug Discovery
Nov 29, 2016: AMRI Announces API Supply Agreement with Shire
Nov 08, 2016: AMRI ANNOUNCES THIRD QUARTER 2016 RESULTS
Oct 03, 2016: AMRI to Unveil Powerful Portfolio of APIs and Capabilities at CPhI in Barcelona
Aug 29, 2016: Albany Molecular Research announces restructuring plan of certain operations in U.S.and Europe
Aug 04, 2016: AMRI Announces Second Quarter 2016 Results
Jul 27, 2016: UB CAT awards over $500K to innovative life sciences companies
Jun 14, 2016: AMRI Selected as a Dedicated Chemical Biology Consortium Center to Expand Drug Development
May 10, 2016: AMRI Announces First Quarter 2016 Results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Albany Molecular Research Inc, Key Facts
Albany Molecular Research Inc, Key Employees
Albany Molecular Research Inc, Key Employee Biographies
Albany Molecular Research Inc, Major Products and Services
Albany Molecular Research Inc, Number of Pipeline Products by Development Stage
Albany Molecular Research Inc, History
Albany Molecular Research Inc, Subsidiaries
Albany Molecular Research Inc, Key Competitors
Albany Molecular Research Inc, Ratios based on current share price
Albany Molecular Research Inc, Annual Ratios
Albany Molecular Research Inc, Annual Ratios (Cont.1)
Albany Molecular Research Inc, Interim Ratios
Albany Molecular Research Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Albany Molecular Research Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Albany Molecular Research Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Albany Molecular Research Inc, Pipeline Products by Therapy Area
Albany Molecular Research Inc, Pipeline Products by Development Phase
Albany Molecular Research Inc, Performance Chart (2012 - 2016)
Albany Molecular Research Inc, Ratio Charts
Albany Molecular Research Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Albany Molecular Research Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Pharmaceutical Product Development LLC
inVentiv Health Clinical LLC
Criterium Inc
Covance Inc
Almac Group Ltd
Skip to top


Ask Your Question

Albany Molecular Research Inc (AMRI) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: